Our conventional GWAS analyses (adjusted for BMI or not) report that variation at the GCKR, TRIB1, MAU2/TM6SF2, APOE, and PNPLA3 loci may be linked to NAFLD. Here, TM6SF2 is linked to metabolic dysfunction-associated steatotic liver disease.